サンレン・デコクションは,腸内細菌群とマクロファージの分極化を調節し,腸内バリア機能を向上させ,潰瘍性大腸炎を緩和する
Shujuan Zhang1,2,3, BangHua Li4, Xiaoqun Han2
12Nd Abdominal Surgery Department, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, 330029, Jiangxi, People's Republic of China.
Chinese medicine
|August 21, 2025
まとめ
サンレン・デコクション (SRD) は,炎症を軽減し,腸の健康を改善することで,潰瘍性大腸炎 (UC) を効果的に治療します. この伝統的な中国医学は 炎症性遺伝子を標的にし 腸内細菌を統合的に管理します
科学分野:
- 薬理学について
- 胃腸内科
- 免疫学
背景:
- 潰瘍性大腸炎 (UC) は慢性炎症性腸疾患で,重要な胃腸障害と粘膜損傷が特徴です.
- サンレン・デコクション (SRD) のような伝統的な中国医学 (TCM) の薬剤は,歴史的に胃腸疾患に使用されてきたが,UCにおけるそのメカニズムは科学的解明を必要としている.
研究 の 目的:
- 統合的アプローチを用いて,潰瘍性大腸炎 (UC) の管理におけるSanren Decoction (SRD) の薬理学的メカニズムを調査する.
- UCの病原性において,SRDの影響を受ける主要な分子標的と経路を特定する.
主な方法:
- ネットワーク薬理学を用いて,SRDを標的とした87のUCに関連する遺伝子を特定した.
- SRD化合物とプロスタグランジン・エンドペロキシド合成酵素2 (PTGS2) の間の分子ドッキングで検証された相互作用.
- in vivo試験では,DSS誘発性大腸炎のマウスモデルを使用して,SRDの治療効果を評価した.
主要な成果:
- SRDは,PTGS2を標的にし,M1からM2のフェノタイプへのマクロファージの偏分を調節する重要な抗炎症効果を示した.
- SRD治療は,大腸炎のマウスモデルにおける臨床的および組織病理学的損傷を改善した.
- SRDは腸内微生物の組成を変えて有益な細菌を増やし,代謝経路に影響を与えた.
結論:
- サンレン・デコクション (SRD) は,多標的,多経路メカニズムにより,潰瘍性大腸炎 (UC) に対する包括的な治療の可能性を示しています.
- 炎症を軽減し,腸内壁を修復し,腸内微生物群のバランスを取り戻す能力は,UCの臨床応用を支持する.
関連する概念動画
01:29Drugs for Treatment of Ulcerative Colitis in IBD
236
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
236
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
267
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
267
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
321
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
321
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
419
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
419
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
202
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
202
01:29Inflammatory Bowel Disease IV: Pharmacological Management
189
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
189